Descriptor
| Cancer | 2 |
| Higher Education | 2 |
| Pharmacology | 2 |
| Acquired Immune Deficiency… | 1 |
| College Science | 1 |
| DNA | 1 |
| Disease Control | 1 |
| Drug Therapy | 1 |
| Drug Use | 1 |
| Enzymes | 1 |
| Futures (of Society) | 1 |
| More ▼ | |
Source
| American Journal of… | 1 |
| Science News | 1 |
Author
| Shaw, Stanley M. | 1 |
| Weiss, Rick | 1 |
Publication Type
| Journal Articles | 2 |
| Information Analyses | 1 |
| Reports - Descriptive | 1 |
Education Level
Audience
| Researchers | 1 |
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewedShaw, Stanley M. – American Journal of Pharmaceutical Education, 1990
Recent advances in the development of radionuclide labeled monoclonal antibodies as radiopharmaceuticals should result in commercially available products in the near future. This presentation describes mechanisms by which radiation can destroy cells, factors influencing the potential for successful treatment, concepts to understanding the use of…
Descriptors: Cancer, Drug Therapy, Futures (of Society), Higher Education
Weiss, Rick – Science News, 1991
Discussed is a designer-drug technology called antisense which blocks messenger RNA's ability to carry information to protein producing sites in the cell. The applications of this drug to AIDS research, cancer therapy, and other diseases are discussed. (KR)
Descriptors: Acquired Immune Deficiency Syndrome, Cancer, College Science, Disease Control
